Black Diamond Therapeutics (BDTX) Other Gross PP&E Adjustments: 2018-2021
Historic Other Gross PP&E Adjustments for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to -$25.2 million.
- Black Diamond Therapeutics' Other Gross PP&E Adjustments fell 212.01% to -$25.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$57.9 million, marking a year-over-year decrease of 602.54%. This contributed to the annual value of -$9.3 million for FY2020, which is 11708.75% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$25.2 million for Q3 2021, which was down 139.22% from -$10.5 million recorded in Q2 2021.
- In the past 5 years, Black Diamond Therapeutics' Other Gross PP&E Adjustments ranged from a high of $234,000 in Q4 2018 and a low of -$25.2 million during Q3 2021.
- Its 3-year average for Other Gross PP&E Adjustments is -$8.3 million, with a median of -$8.7 million in 2020.
- Data for Black Diamond Therapeutics' Other Gross PP&E Adjustments shows a maximum YoY crashed of 12,918.52% (in 2021) over the last 5 years.
- Over the past 4 years, Black Diamond Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $234,000 in 2018, then plummeted by 65.81% to $80,000 in 2019, then tumbled by 11,708.75% to -$9.3 million in 2020, then plummeted by 212.01% to -$25.2 million in 2021.
- Its Other Gross PP&E Adjustments was -$25.2 million in Q3 2021, compared to -$10.5 million in Q2 2021 and -$12.8 million in Q1 2021.